A Clinical Trial of TQB3015 Tablets in Patients With Advanced Malignant Cancer

Clinical trial NCT06165809 · WITHDRAWN

Trial details

NCT number: NCT06165809
Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Neoplasm

Start date: 2023-12-01
Primary completion: 2024-05-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.